Hint mode is switched on Switch off

scPharmaceuticals, ordinary share
SCPH, US8106481059

Add a stock to WL
Choose all Reset all
scPharmaceuticals, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

  • Issuer
  • Full borrower / issuer name
    scPharmaceuticals Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    SCPH
  • Placement
    17.11.2017
  • Lock up period
    180
  • Number of papers
    6,400,000
  • Volume of raised funds
    89.6 mln USD
  • Final placement price
    14 USD
  • Price change since placement date
    -100%
  • By capitalization
    246.54 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    SCPH
  • Placement
    22.05.2020
  • Lock up period
    180
  • Number of papers
    5,780,347
  • Volume of raised funds
    50 mln USD
  • Placement share
    21.6%
  • Final placement price
    8.65 USD
  • Price change since placement date
    -100%
  • By capitalization
    231.49 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    SCPH
  • Placement
    23.11.2022
  • Lock up period
    180
  • Number of papers
    34,022,121
  • Volume of raised funds
    34.76 mln USD
  • Placement share
    19.46%
  • Final placement price
    5.25 USD
  • Price change since placement date
    -100%
  • By capitalization
    178.62 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    SCPH
  • Placement
    13.08.2024
  • Lock up period
    180
  • Number of papers
    12,000,000
  • Volume of raised funds
    48 mln USD
  • Placement share
    24.97%
  • Final placement price
    4 USD
  • Price change since placement date
    -100%
  • By capitalization
    192.22 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2025
I q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
Show all Hide

Indicators

News

07/10/2025 scPharmaceuticals: Termination Of A Material Definitive Agreement, Completion Of Acquisition Or Disposition Of Assets, Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Material Modification To Rights Of Security Holders, Changes In Control Of Registrant, Departure Of Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Amendments To Articles Of Incorporation Or Bylaws, Financial Statements And Exhibits
23/09/2025 scPharmaceuticals: Entry Into A Material Definitive Agreement, Creation Of A Direct Financial Obligation Or An Obligation Under An, Financial Statements And Exhibits
24/08/2025 scPharmaceuticals: Entry Into A Material Definitive Agreement, Regulation Fd Disclosure, Financial Statements And Exhibits
20/08/2025 scPharmaceuticals: Entry Into A Material Definitive Agreement, Financial Statements And Exhibits
03/06/2025 scPharmaceuticals: Submission Of Matters To A Vote Of Security Holders
All organization news

Holders

Industry Leaders

Registration is required to get access.